Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells

被引:44
|
作者
Li, Lin [1 ]
Tian, Hui [1 ]
Chen, Zhitao [2 ]
Yue, Weiming [1 ]
Li, Shuhai [1 ]
Li, Wenjun [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Thorac Surg, Jinan 250012, Peoples R China
[2] Shandong Univ, Jinan Cent Hosp, Dept Thorac Surg, Jinan 250012, Peoples R China
基金
中国国家自然科学基金;
关键词
mesenchymal stem cell; lung cancer; proliferation; vascular endothelial growth factor; BONE-MARROW; STROMAL CELLS; TUMOR-GROWTH; MECHANISMS; VEGF;
D O I
10.1093/abbs/gmq118
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human mesenchymal stem cells (hMSCs) are mostly studied for their potential clinical use. Recently, much attention in the field of cancer research has been paid to hMSCs. In this study, we investigated the influence of hMSCs on the proliferation of lung cancer cell lines SK-MES-1 and A549 in vitro and in vivo by using a co-culture system and the hMSCs-conditioned medium. Our results demonstrated that hMSCs could inhibit the proliferation of SK-MES-1 and A549 cells, and induce the apoptosis of tumor cells in vitro via some soluble factors. Animal study showed that these soluble factors from hMSCs could suppress tumorigenesis and tumor angiogenesis by treating preliminarily tumor cells with the hMSCs-conditioned medium. The downregulated expression of vascular endothelial growth factor in tumor cells might be the mechanism of interference in tumor angiogenesis, which was verified by western blot analysis and immunohistochemistry assay. Taken together, our results suggested that the hMSCs could inhibit tumor cell growth by secreting some soluble factors.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 50 条
  • [41] Human mesenchymal stem cells support proliferation and multilineage differentiation of human hematopoietic stem cells.
    Cheng, L
    Mbalaviele, G
    Liu, X
    Novelli, E
    Vanguri, P
    Mosca, J
    Deans, R
    Civin, CI
    Thiede, MA
    BLOOD, 1998, 92 (10) : 57A - 57A
  • [42] Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy
    Kolluri, Krishna K.
    Laurent, Geoff J.
    Janes, Sam M.
    RESPIRATION, 2013, 85 (06) : 443 - 451
  • [43] Fractal Dimension Characteristics of Human Mesenchymal Stem Cell Proliferation
    Rabbani, M.
    Shadpour, M. Tafazzoli
    Malekabadi, Z. Goli
    Janmaleki, M.
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT 10: BIOMATERIALS, CELLULAR AND TISSUE ENGINEERING, ARTIFICIAL ORGANS, 2009, 25 (10): : 219 - +
  • [44] The effects of mesenchymal stem cells on lymphoblastic leukemia cell proliferation
    Cetintas, Vildan Bozok
    Aktug, Huseyin
    Oltulu, Fatih
    Keskinoglu, Ahmet
    Del Castello, Buket Erer
    Taskiran, Dilek
    JOURNAL OF BUON, 2014, 19 (04): : 1006 - 1017
  • [45] Preconditioning Mesenchymal Stem Cells With Caspase Inhibition and Hyperoxia Prior to Hypoxia Exposure Increases Cell Proliferation
    Saini, Uksha
    Gumina, Richard J.
    Wolfe, Brian
    Kuppusamy, M. Lakshmi
    Kuppusamy, Periannan
    Boudoulas, Konstantinos Dean
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (11) : 2612 - 2623
  • [46] Esculetin inhibits the proliferation of human lung cancer cells by targeting epithelial-to-mesenchymal transition of the cells
    Li, Hua
    Wang, Qi
    Wang, Yunli
    Xu, Ze
    Han, Zhong
    CELLULAR AND MOLECULAR BIOLOGY, 2019, 65 (07) : 95 - 98
  • [47] Proliferation and differentiation of human mesenchymal stem cells is affected by human renal tubular cells
    Baer, Patrick
    Martin, Brzoska
    Helmut, Geiger
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 28 - 28
  • [48] Increasing the Proliferation of Hematopoietic Stem Cell Through a Dynamic Co-culture of Human Mesenchymal Stem Cells
    Placone, Jesse K.
    Koshatwar, Sampada
    Fisher, John P.
    TISSUE ENGINEERING PART A, 2014, 20 : S136 - S136
  • [49] Inhibition of cell proliferation, invasion and migration by ursolic acid in human lung cancer cell lines
    Huang, Chun-Yin
    Lin, Chia-Yu
    Tsai, Chia-Wen
    Yin, Mei-Chin
    TOXICOLOGY IN VITRO, 2011, 25 (07) : 1274 - 1280
  • [50] Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition
    Ulanet, Danielle
    Jha, Abhishek
    Couto, Kiley
    Choe, Sung
    Wang, Amanda
    Woo, Hin-Koon
    Steadman, Mya
    DeLaBarre, Byron
    Gross, Stefan
    Driggers, Edward
    Dorsch, Marion
    Hurov, Jonathan
    CANCER & METABOLISM, 2014, 2